A Phase I study that looked at the safety and distribution of dapivirine gel when administered rectally as a lubricant (without an applicator) to determine whether enough drug is delivered in the tissue to feasibly provide HIV protection. The study was conducted in the U.S. and enrolled 16 participants.
Bottoms Are Up at the HIV Research for Prevention Virtual Conference
2-February-2021
See Also
MTN-033 Protocol